You are here

EU authorizes 2 new medicines for people at risk of severe COVID

Primary tabs

Thu, 2021-11-11 12:06 — mike kraft

EU authorizes 2 medicines for people at risk of severe COVID AMSTERDAM (AP) — The European Medicines Agency has recommended the authorization of two new medicines against the coronavirus for people at risk of severe disease. In a statement on Thursday, the EU drug regulator said it had concluded that the monoclonal antibody treatments — a combination of casirivimab and imdevimab, and the drug regdanvimab — have both been proven to significantly reduce the risk of hospitalization and death in patients vulnerable to serious COVID-19. AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

Medical - global

Log in or register to post comments

Page loaded in 0.737 seconds.